PROLIA® is a monoclonal antibody. Monoclonal antibodies are made to target and destroy only certain cells in the body. This may help to protect healthy cells from damage. The PROLIA® brand of denosumab is used to treat osteoporosis in postmenopausal women who have a high risk of bone fracture. PROLIA® is also used to increase bone mass in women and men with a high risk of bone fracture caused by receiving treatments for certain types of cancer.
